Krebs Biochemicals & Industries Limited
NSE: KREBSBIO BSE: KREBSBIO
NSE
74.89
0.33 (0.44%)
Prev Close
74.56
Open Price
74
Volume
2,676
Today Low / High
74 / 77.9
52 WK Low / High
66.12 / 129.07
Range
71 - 79
BSE
73.26
-1.39 (-1.86%)
Prev Close
74.65
Open Price
74.65
Volume
101
Today Low / High
73.26 / 74.65
52 WK Low / High
63.55 / 129
Range
70 - 77
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 74.89 (target range: 71 - 79), reflecting a change of 0.33 (0.4426%). On the BSE, it is listed at 73.26 (target range: 70 - 77), showing a change of -1.39 (-1.86202%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
22 Aug
74.00
1.20%
21 Aug
74.83
-0.36%
20 Aug
77.20
-3.07%
19 Aug
78.00
-1.03%
18 Aug
75.33
1.14%
14 Aug
75.00
0.44%
13 Aug
77.00
-1.42%
12 Aug
77.21
1.22%
11 Aug
77.87
-0.36%
08 Aug
76.27
-2.06%
07 Aug
76.16
1.54%
06 Aug
77.90
-1.14%
05 Aug
77.99
-0.63%
04 Aug
78.00
-0.51%
01 Aug
77.00
-0.27%
31 Jul
79.00
-0.77%
30 Jul
76.37
1.86%
29 Jul
79.75
-4.24%
28 Jul
80.00
-4.24%
Krebs Biochemicals & Industries Limited Graph
Krebs Biochemicals & Industries Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Krebs Biochemicals & Industries Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 74.89, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 73.26 | 73.99 | 66.59 - 81.39 |
| 74.73 | 59.78 - 89.67 | ||
| 75.46 | 52.82 - 98.10 | ||
| Bearish Scenario | 73.26 | 72.53 | 65.27 - 79.78 |
| 71.79 | 57.44 - 86.15 | ||
| 71.06 | 49.74 - 92.38 |
Overview of Krebs Biochemicals & Industries Limited
ISIN
INE268B01013
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
23,363
Market Cap
1,614,673,334
Last Dividend
0
Official Website
IPO Date
2016-10-27
DCF Diff
N/A
DCF
0
Financial Ratios Every Investor Needs
Stock Dividend of KREBSBIO
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2005-09-14 | September 14, 05 | 2.89781 | 3 | 2005-09-16 | 2005-10-01 | 2005-06-09 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 43.31 Cr | 5.56 Cr | 37.76 Cr | 0.8717 | 0.00 Cr | 0.00 Cr | -21.72 Cr | -26.94 Cr | -12.50 | -14.32 Cr | -0.6220 |
| 2024-03-31 | 50.42 Cr | 61.30 Cr | -10.87 Cr | -0.2157 | 0.00 Cr | 0.60 Cr | -15.20 Cr | -19.73 Cr | -9.15 | -8.27 Cr | -0.3913 |
| 2023-03-31 | 52.13 Cr | 42.35 Cr | 9.78 Cr | 0.1876 | 0.00 Cr | 0.86 Cr | -21.72 Cr | -24.69 Cr | -11.45 | -15.16 Cr | -0.4736 |
| 2022-03-31 | 59.70 Cr | 65.47 Cr | -5.76 Cr | -0.0965 | 1.64 Cr | 1.14 Cr | -39.49 Cr | -44.53 Cr | -20.65 | -32.85 Cr | -0.7458 |
| 2021-03-31 | 38.61 Cr | 51.60 Cr | -12.99 Cr | -0.3365 | 0.00 Cr | 0.67 Cr | -23.04 Cr | -28.36 Cr | -14.45 | -16.96 Cr | -0.7346 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.14 Cr | 169.04 Cr | 315.27 Cr | -146.2388 Cr | 212.21 Cr | 212.07 Cr | 6.03 Cr | 146.47 Cr | 0.00 Cr | 0.00 Cr | 2.85 Cr | 103.5260 Cr |
| 2024-03-31 | 0.14 Cr | 178.17 Cr | 297.39 Cr | -119.2167 Cr | 238.68 Cr | 238.61 Cr | 10.24 Cr | 149.74 Cr | 0.00 Cr | 0.00 Cr | -0.47 Cr | 61.8339 Cr |
| 2023-03-31 | 0.09 Cr | 174.98 Cr | 274.44 Cr | -99.4623 Cr | 183.24 Cr | 183.15 Cr | 12.36 Cr | 149.05 Cr | 0.00 Cr | 0.00 Cr | 2.09 Cr | 49.1047 Cr |
| 2022-03-31 | 0.03 Cr | 189.81 Cr | 264.90 Cr | -75.0932 Cr | 188.10 Cr | 188.07 Cr | 25.86 Cr | 144.93 Cr | 0.00 Cr | 0.00 Cr | 2.23 Cr | 78.0640 Cr |
| 2021-03-31 | 0.71 Cr | 159.22 Cr | 201.95 Cr | -42.7329 Cr | 126.14 Cr | 125.55 Cr | 16.89 Cr | 128.21 Cr | 0.00 Cr | 0.00 Cr | 0.04 Cr | 48.1924 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -7.8910 Cr | -4.9696 Cr | 12.8648 Cr | -11.4542 Cr | 0.0042 Cr | 0.1416 Cr | -3.5632 Cr | -26.9240 Cr | 18.7789 Cr | 0.0000 Cr | 3.7649 Cr |
| 2024-03-31 | 2.3040 Cr | -7.8167 Cr | 5.5641 Cr | -5.0233 Cr | 0.0516 Cr | 0.1374 Cr | -9.4150 Cr | -19.7284 Cr | 10.2535 Cr | 0.0000 Cr | 2.1492 Cr |
| 2023-03-31 | -24.7132 Cr | -12.6450 Cr | 37.3433 Cr | -35.5836 Cr | -0.0148 Cr | 0.0858 Cr | -10.8704 Cr | -24.6919 Cr | 40.3165 Cr | 0.0000 Cr | 13.6170 Cr |
| 2022-03-31 | -17.2162 Cr | -22.8995 Cr | 39.5056 Cr | -40.7363 Cr | -0.6101 Cr | 0.1006 Cr | -23.5201 Cr | -44.5268 Cr | 32.3835 Cr | 0.0000 Cr | -8.9622 Cr |
| 2021-03-31 | -14.5748 Cr | -22.5493 Cr | 37.6605 Cr | -40.0812 Cr | 0.5364 Cr | 0.7107 Cr | -25.5064 Cr | -28.3586 Cr | 33.4906 Cr | 0.0000 Cr | -1.6049 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 5.48 Cr | 0.29 Cr | 5.19 Cr | 0.9472 | -3.69 Cr | -5.32 Cr | -2.47 | -2.08 Cr | -0.9714 |
| 2025-03-31 | 6.10 Cr | 0.57 Cr | 5.53 Cr | 0.9071 | -6.98 Cr | -8.27 Cr | -3.84 | -5.07 Cr | -1.3554 |
| 2024-12-31 | 11.47 Cr | 1.31 Cr | 10.16 Cr | 0.8858 | -6.43 Cr | -7.74 Cr | -3.59 | -4.46 Cr | -0.6749 |
| 2024-09-30 | 12.86 Cr | 2.42 Cr | 10.43 Cr | 0.8117 | -4.42 Cr | -5.76 Cr | -2.67 | -2.62 Cr | -0.4481 |
| 2024-06-30 | 12.89 Cr | 1.26 Cr | 11.63 Cr | 0.9024 | -3.89 Cr | -5.17 Cr | -2.40 | -2.16 Cr | -0.4012 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.14 Cr | 0.20 Cr | 0.34 Cr | 0.05 Cr | 6.03 Cr | 10.26 Cr | 146.47 Cr | 169.04 Cr | 315.27 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 0.14 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 130.15 Cr |
| 2024-09-30 | 0.14 Cr | 11.06 Cr | 11.21 Cr | 2.57 Cr | 7.73 Cr | 26.21 Cr | 147.19 Cr | 185.20 Cr | 315.35 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 0.14 Cr | 0.00 Cr | 0.00 Cr | 0.14 Cr | 0.00 Cr | 0.00 Cr | 119.22 Cr |
| 2024-03-31 | 0.14 Cr | 2.50 Cr | 0.14 Cr | 4.73 Cr | 10.24 Cr | 17.44 Cr | 149.74 Cr | 178.17 Cr | 297.39 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -8.27 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | -7.74 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | -5.76 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | -5.17 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | -5.85 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2019-01-31 | January 31, 19 | 207:200 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,641.80 | ₹3,939,137,904,000.00 | ₹2,098,280.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,151.50 | ₹1,633,032,553,500.00 | ₹681,521.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,685.30 | ₹1,247,271,358,500.00 | ₹279,863.00 |
| Mankind Pharma Limited | MANKIND | ₹2,606.80 | ₹1,075,901,331,568.00 | ₹731,305.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,277.60 | ₹1,063,387,459,020.00 | ₹1,229,762.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹988.80 | ₹994,960,224,000.00 | ₹307,413.00 |
| Lupin Limited | LUPIN | ₹1,974.70 | ₹901,938,300,900.00 | ₹380,522.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,426.00 | ₹648,759,690,000.00 | ₹99,581.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,050.40 | ₹610,074,420,800.00 | ₹1,872,840.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,937.30 | ₹546,707,997,300.00 | ₹466,930.00 |
| Laurus Labs Limited | LAURUSLABS | ₹879.10 | ₹474,560,157,500.00 | ₹1,548,001.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,418.40 | ₹359,853,753,600.00 | ₹437,395.00 |
| Cohance Lifesciences Limited | COHANCE | ₹884.70 | ₹338,457,031,978.00 | ₹105,334.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,638.50 | ₹329,643,636,000.00 | ₹49,045.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,747.90 | ₹273,268,433,900.00 | ₹250,994.00 |
| Piramal Enterprises Limited | PEL | ₹1,167.70 | ₹264,691,900,600.00 | ₹183,898.00 |
| Eris Lifesciences Limited | ERIS | ₹1,768.70 | ₹240,909,320,900.00 | ₹37,828.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,479.40 | ₹240,371,432,600.00 | ₹246,819.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,433.00 | ₹210,825,000,000.00 | ₹11,150.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹974.60 | ₹191,570,299,800.00 | ₹29,498.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,888.00 | ₹178,181,651,200.00 | ₹28,474.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,083.00 | ₹172,501,323,000.00 | ₹140,398.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹2,168.10 | ₹164,800,966,770.00 | ₹172,510.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹882.45 | ₹158,055,619,500.00 | ₹259,072.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹458.50 | ₹111,252,274,000.00 | ₹945,550.00 |
| Procter & Gamble Health Limited | PGHL | ₹6,581.50 | ₹109,248,951,100.00 | ₹46,177.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹851.90 | ₹83,308,067,710.00 | ₹36,218.00 |
| Strides Pharma Science Limited | STAR | ₹865.50 | ₹79,775,471,850.00 | ₹92,326.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹863.25 | ₹78,240,335,715.00 | ₹294,141.00 |
| FDC Limited | FDC | ₹474.65 | ₹77,277,766,500.00 | ₹198,253.00 |
| Innova Captab Limited | INNOVACAP | ₹911.35 | ₹52,151,939,956.00 | ₹70,484.00 |
| Suven Life Sciences Limited | SUVEN | ₹230.75 | ₹50,320,575,500.00 | ₹56,095.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹146.08 | ₹47,406,173,760.00 | ₹195,028.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹483.05 | ₹44,087,973,500.00 | ₹160,106.00 |
| Sequent Scientific Limited | SEQUENT | ₹175.85 | ₹44,021,409,750.00 | ₹240,104.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹772.20 | ₹39,165,289,020.00 | ₹31,316.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,358.20 | ₹39,002,269,800.00 | ₹5,512.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹363.25 | ₹36,425,983,500.00 | ₹39,528.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹502.80 | ₹35,400,036,240.00 | ₹9,585.00 |
| Hikal Limited | HIKAL | ₹254.90 | ₹31,429,424,900.00 | ₹3,140,867.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹631.60 | ₹30,413,434,800.00 | ₹53,855.00 |
| IOL Chemicals and Pharmaceuticals Limited | IOLCP | ₹96.82 | ₹28,419,284,140.00 | ₹848,541.00 |
| Alembic Limited | ALEMBICLTD | ₹105.52 | ₹27,095,636,534.00 | ₹249,022.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹49.03 | ₹26,866,184,620.00 | ₹2,369,065.00 |
| Indoco Remedies Limited | INDOCO | ₹279.55 | ₹25,787,900,445.00 | ₹12,570.00 |
Key Executives
Chief Financial Officer
Mr. Ritesh Jain
Gender: male
Year Born:
Company Secretary & Compliance Officer
Mr. Rakesh R. Kalbate
Gender: male
Year Born:
MD, Chief Executive Officer & Director
Mr. Jitendra Rameshchandra Shah
Gender: male
Year Born: 1968
FAQs about Krebs Biochemicals & Industries Limited
Who is the CEO of the company?
The CEO is Jitendra Rameshchandra Shah.
What is the current market price of the stock?
The current price is ₹74.89.
What is the 52-week price range?
The range is ₹66.12-129.07.
What is the market capitalization of the company?
The market capitalization is ₹161.47 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is -5.96.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Krebs Biochemicals & Industries Limited (ISIN: INE268B01013) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹161.47 crores and an average daily volume of 23,363 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.